Page last updated: 2024-10-26

racemetirosine and Cardiomyopathy, Dilated

racemetirosine has been researched along with Cardiomyopathy, Dilated in 1 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imperato-McGinley, J1
Gautier, T1
Ehlers, K1
Zullo, MA1
Goldstein, DS1
Vaughan, ED1

Other Studies

1 other study available for racemetirosine and Cardiomyopathy, Dilated

ArticleYear
Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma.
    The New England journal of medicine, 1987, Mar-26, Volume: 316, Issue:13

    Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Cardiomyopathy, Dilated; Catecholamines; Child; Femal

1987